|
TM6SF1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.88820004076717E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.26580004653232E-09 |
| Normal-vs-Stage2 |
5.417100E-04 |
| Normal-vs-Stage3 |
2.177600E-04 |
| Normal-vs-Stage4 |
3.434200E-04 |
| Stage1-vs-Stage2 |
3.811200E-01 |
| Stage1-vs-Stage3 |
4.922800E-01 |
| Stage1-vs-Stage4 |
3.651200E-01 |
| Stage2-vs-Stage3 |
2.415600E-01 |
| Stage2-vs-Stage4 |
2.016000E-01 |
| Stage3-vs-Stage4 |
8.812800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.1609999961415E-08 |
| Normal-vs-AfricanAmerican |
8.414500E-04 |
| Normal-vs-Asian |
1.644240E-02 |
| Caucasian-vs-AfricanAmerican |
5.267000E-01 |
| Caucasian-vs-Asian |
1.008420E-02 |
| AfricanAmerican-vs-Asian |
7.175800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.05769973177428E-10 |
| Normal-vs-Female |
2.22749999999605E-05 |
| Male-vs-Female |
1.656320E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.664300E-03 |
| Normal-vs-Age(41-60Yrs) |
9.52450007751793E-10 |
| Normal-vs-Age(61-80Yrs) |
9.5891999996045E-07 |
| Normal-vs-Age(81-100Yrs) |
1.807430E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.715600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.921400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.537800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.388600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.816000E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.644200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.391510E-02 |
| Normal-vs-Grade 2 |
1.63609999992431E-08 |
| Normal-vs-Grade 3 |
1.68529999955425E-08 |
| Normal-vs-Grade 4 |
7.537300E-03 |
| Grade 1-vs-Grade 2 |
4.499200E-01 |
| Grade 1-vs-Grade 3 |
6.948800E-01 |
| Grade 1-vs-Grade 4 |
7.093400E-01 |
| Grade 2-vs-Grade 3 |
5.841400E-01 |
| Grade 2-vs-Grade 4 |
9.270000E-02 |
| Grade 3-vs-Grade 4 |
1.098360E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.27799999999545E-06 |
| Normal-vs-ccB subtype |
1.0888999701919E-09 |
| ccA subtype-vs-ccB subtype |
1.377760E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.06309999587029E-08 |
| Normal-vs-N1 |
2.033900E-02 |
| N0-vs-N1 |
2.672600E-01 |
|
|
